BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37681645)

  • 21. Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer.
    Tran E; Spiceland C; Sandhu NP; Jatoi A
    Am J Hosp Palliat Care; 2016 Apr; 33(3):272-5. PubMed ID: 25552305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and chance of reversal after intestinal stoma formation during cytoreductive surgery for advanced ovarian cancer; a population-based cohort study.
    Kofoed NG; Falconer H; Vanky H; Johansson H; Abraham-Nordling M; Salehi S
    Gynecol Oncol; 2023 Mar; 170():259-265. PubMed ID: 36738484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
    Lawal AO; Musekiwa A; Grobler L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents.
    Carter J; Valmadre S; Dalrymple C; Atkinson K; Young C
    Gynecol Oncol; 2002 Jan; 84(1):176-9. PubMed ID: 11748998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.
    Gillette-Cloven N; Burger RA; Monk BJ; McMeekin DS; Vasilev S; DiSaia PJ; Kohler MF
    J Am Coll Surg; 2001 Dec; 193(6):626-32. PubMed ID: 11768679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage surgery due to bowel obstruction in advanced or relapsed ovarian cancer resulting in short bowel syndrome and long-life total parenteral nutrition: surgical and clinical outcome.
    Fotopoulou C; Braicu EI; Kwee SL; Kuhberg M; Richter R; Pietzner K; Feldheiser A; Bahra M; Schmidt SC; Sehouli J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1495-500. PubMed ID: 24189059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients.
    Armbrust R; Chekerov R; Sander S; Biebl M; Chopra S; Krell J; Rinne N; Nixon K; Fotopoulou C; Sehouli J
    Arch Gynecol Obstet; 2022 Apr; 305(4):963-968. PubMed ID: 34596738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.
    Zachou G; El-Khouly F; Dilley J
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD006119. PubMed ID: 37650760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
    Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma.
    Rauh-Hain JA; Olawaiye AB; Munro M; Ko E; Alarcon IA; Del Carmen MG; Duska L
    Ann Surg Oncol; 2010 Mar; 17(3):853-60. PubMed ID: 20183913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery performed later in the week is associated with inferior survival in advanced ovarian cancer.
    Groes-Kofoed N; Hasselgren E; Björne H; Johansson H; Falconer H; Salehi S
    Acta Oncol; 2021 Nov; 60(11):1513-1519. PubMed ID: 34448442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of bowel obstruction in advanced ovarian carcinoma.
    Krebs HB; Goplerud DR
    Obstet Gynecol; 1983 Mar; 61(3):327-30. PubMed ID: 6823374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer.
    Rauh-Hain JA; del Carmen M; Horowitz NS; Alarcon IA; Ko E; Goodman AK; Olawaiye AB
    BJOG; 2010 Jan; 117(1):32-8. PubMed ID: 20002368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for ovarian cancer: rationale and guidelines.
    Greer BE; Swensen RE; Gray HJ
    J Natl Compr Canc Netw; 2004 Nov; 2(6):561-8. PubMed ID: 19780300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer.
    Bryan DN; Radbod R; Berek JS
    Int J Gynecol Cancer; 2006; 16(1):125-34. PubMed ID: 16445622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic CT findings of malignant bowel obstruction in patients with advanced ovarian cancer.
    Miccò M; Sbarra M; Gui B; Bianco NC; Rodolfino E; Manfredi R
    Tumori; 2020 Apr; 106(2):149-154. PubMed ID: 31739760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study.
    Winner M; Mooney SJ; Hershman DL; Feingold DL; Allendorf JD; Wright JD; Neugut AI
    Dis Colon Rectum; 2013 Jul; 56(7):834-43. PubMed ID: 23739189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of body mass index on ovarian cancer survival varies by stage.
    Bandera EV; Lee VS; Qin B; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    Br J Cancer; 2017 Jul; 117(2):282-289. PubMed ID: 28588323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.